Foresite Capital Management V, LLC
10% Owner
19 filings on record here, covering LTGO, GPCR, ORKA, BEAM, CTRN, SYRE, PLBY, NN. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-10
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Buy | LTGO | Latigo Biotherapeutics, Inc. | $2,520,000 |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
| Convert | LTGO | Latigo Biotherapeutics, Inc. | |
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-03
CORPORATEFiled 2026-07-28
CORPORATEFiled 2026-07-28
CORPORATEFiled 2026-07-28
CORPORATEFiled 2026-07-24
| Sell | GPCR | Structure Therapeutics Inc. | $68,446 |
| Sell | GPCR | Structure Therapeutics Inc. | $805,376 |
CORPORATEFiled 2026-07-08
CORPORATEFiled 2026-07-01
| Convert | ORKA | Oruka Therapeutics, Inc. | |
| Sell | ORKA | Oruka Therapeutics, Inc. | $300,014,406 |
| Convert | ORKA | Oruka Therapeutics, Inc. | |
CORPORATEFiled 2026-06-29
| Sell | BEAM | Beam Therapeutics Inc. | $1,172,025 |
| Sell | BEAM | Beam Therapeutics Inc. | $8,867,467 |
CORPORATEFiled 2026-06-24
| Sell | CTRN | Citi Trends Inc | $42,375,000 |
CORPORATEFiled 2026-06-23
| Convert | SYRE | Spyre Therapeutics, Inc. | |
| Sell | SYRE | Spyre Therapeutics, Inc. | $399,658,667 |
| Convert | SYRE | Spyre Therapeutics, Inc. | |
CORPORATEFiled 2026-06-23
| Sell | PLBY | Playboy, Inc. | $969,674 |
| Sell | PLBY | Playboy, Inc. | $390,221 |
| Sell | PLBY | Playboy, Inc. | $310,317 |
| Sell | PLBY | Playboy, Inc. | $113,707 |
| Sell | PLBY | Playboy, Inc. | $100,224 |
| Sell | PLBY | Playboy, Inc. | $46,696 |
| Sell | PLBY | Playboy, Inc. | $45,009 |
| Sell | PLBY | Playboy, Inc. | $24,153 |
CORPORATEFiled 2026-06-22
| Convert | NN | NEXTNAV INC. | $50,111,109 |
| Convert | NN | NEXTNAV INC. | |
CORPORATEFiled 2026-06-22
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.